



Biosimilar medicines are transforming treatment by enabling better access to […]
Read morePharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]
Read moreThe European Semester Country Specific Recommendations show that healthcare systems […]
Read moreSpeaking at the B20 Health Conference in Berlin, IFPMA Director-General […]
Read moreThe new report on The Impact of Biosimilar Competition in […]
Read moreThe European pharmaceutical industry welcomes the 3rd workshop on access […]
Read moreOver 100 participants explored different ways and opportunities to ensure […]
Read more